Skip to main content

Advertisement

SpringerLink
Log in

Formulation development and evaluation of drug-in-adhesive-type transdermal patch of metoclopramide HCl

  • Original Paper
  • Published:
Polymer Bulletin Aims and scope Submit manuscript

Abstract

The objective was to design and develop a drug-in-adhesive-type transdermal patch formulation of metoclopramide HCl, which is used as an effective antiemetic, dopaminergic antagonist agent. In DIA patches, drug is directly embedded in the polymeric adhesive layer and permeates through the skin to provide systemic effect, avoiding gastrointestinal tract complications, including the first-pass metabolism. Six different patch formulations were prepared by a solvent evaporation method using varying metoclopramide HCl concentrations using acrylate polymer DURO-TAK® 387/2510 for adhesive support. In vitro permeation profiles and parameters were obtained by using the skin of hairless albino Wistar rats. The influence of drug content on the rate of permeation was investigated, and patch formulation was optimized based on Q12, flux, and lag time. The effect of permeation enhancers (EO and PG) on the permeation rate of metoclopramide HCl was also studied. The skin irritation study was performed to observe the hypersensitivity against the patch component. Stability studies of the optimized formulation of a transdermal patch for three months at three different temperatures were investigated. The transdermal patch formulation containing 10% w/w metoclopramide HCl was capable of effectively delivering metoclopramide HCl for systemic effect without any skin irritation. It has Q12 of 3.892 ± 0.0043 mg/cm2, flux rate of 0.2501 mg/cm2 h, and the coefficient of permeability of 6.25E−02 cm/h with a lag time of 0.442 h. The stability data revealed that the optimized patch formulation could be stored at 4 °C in the refrigerator with a shelf life of 3.53 months. This newly developed metoclopramide transdermal DIA patch is an effective alternative to oral delivery with desirable antiemetic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Maity T (2016) Transdermal drug delivery systems. Int J Curr Res Health Biol Sci 6:1–16

    Google Scholar 

  2. Pundir S, Badola A, Sharma D (2017) Sustained release matrix technology and recent advance in matrix drug delivery system: a review. Int J Drug Res Technol 3(1):8

    Google Scholar 

  3. Patel D, Chaudhary SA, Parmar B, Bhura N (2012) Transdermal drug delivery system: a review. Pharma Innov 1 (4)

  4. Gunjkar V, Firke S, Sarje S, Roge A (2015) Transdermal drug delivery system: a review. Int J Pharm Chem Sci 4:148–153

    Google Scholar 

  5. Chandrashekar N, Rani RS (2008) Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci 70(1):94

    Article  CAS  Google Scholar 

  6. Liu C, Hui M, Quan P, Fang L (2016) Drug in adhesive patch of palonosetron: effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation. Int J Pharm 511(2):1088–1097

    Article  CAS  Google Scholar 

  7. Smith DS, Ferris CD (2003) Current concepts in diabetic gastroparesis. Drugs 63(13):1339–1358

    Article  Google Scholar 

  8. Zaki N, Awad G, Mortada N, Abd ElHady S (2006) Rapid-onset intranasal delivery of metoclopramide hydrochloride: part I. Influence of formulation variables on drug absorption in anesthetized rats. Int J Pharm 327(1–2):89–96

    Article  CAS  Google Scholar 

  9. Zaki N, Mortada N, Awad G, Abd ElHady S (2006) Rapid-onset intranasal delivery of metoclopramide hydrochloride: part II: safety of various absorption enhancers and pharmacokinetic evaluation. Int J Pharm 327(1–2):97–103

    Article  CAS  Google Scholar 

  10. Friedman BW, Mulvey L, Esses D, Solorzano C, Paternoster J, Lipton RB, Gallagher EJ (2011) Metoclopramide for acute migraine: a dose-finding randomized clinical trial. Annals Emerg Med 57(5):475–482

    Article  Google Scholar 

  11. Pitrè D, Stradi R (1987) Metoclopramide hydrochloride. Anal Profiles Drug Subst 16:327–360. https://doi.org/10.1016/S0099-5428(08)60560-2

    Article  Google Scholar 

  12. Zhang Y, Cun D, Kong X, Fang L (2014) Design and evaluation of a novel transdermal patch containing diclofenac and teriflunomide for rheumatoid arthritis therapy. Asian J Pharm Sci 9(5):251–259. https://doi.org/10.1016/j.ajps.2014.07.007

    Article  Google Scholar 

  13. Gupta V, Yadav S, Dwivedi AK, Gupta N (2011) Transdermal drug delivery: past, present, future trends. Int J Pharm Life Sci 2(9):308

    Google Scholar 

  14. Nair RS, Ling TN, Abdul Shukkoor MS, Manickam B (2013) Matrix type transdermal patches of captopril: ex vivo permeation studies through excised rat skin. J Pharm Res 6(7):774–779. https://doi.org/10.1016/j.jopr.2013.07.003

    Article  CAS  Google Scholar 

  15. Prausnitz MR, Mitragotri S, Langer R (2004) Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3(2):115

    Article  CAS  Google Scholar 

  16. Jung E, Lee EY, Choi H-K, Ban S-J, Choi S-H, Kim JS, Yoon I-S, Kim D-D (2015) Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: In vitro and in vivo evaluations. Int J Pharm 487(1–2):49–55. https://doi.org/10.1016/j.ijpharm.2015.04.012

    Article  CAS  PubMed  Google Scholar 

  17. Ganti SS, Bhattaccharjee SA, Murnane KS, Blough BE, Banga AK (2018) Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch. Int J Pharm 550(1–2):71–78

    Article  CAS  Google Scholar 

  18. Bhowmick M, Sengodan T (2013) Mechanisms, kinetics and mathematical modelling of transdermal permeation-an updated review. Pharmacie Globale 4(6):1

    Google Scholar 

  19. Rastogi V, Yadav P, Husain A, Verma A (2019) Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization. Drug Dev Ind Pharm 45(4):669–682. https://doi.org/10.1080/03639045.2019.1569035

    Article  CAS  PubMed  Google Scholar 

  20. Patel KN, Patel HK, Patel VA (2012) Formulation and characterization of drug in adhesive transdermal patches of diclofenac acid. Int J Pharm Pharm Sci 4(1):296–299

    CAS  Google Scholar 

  21. Godin B, Touitou E (2007) Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 59(11):1152–1161. https://doi.org/10.1016/j.addr.2007.07.004

    Article  CAS  PubMed  Google Scholar 

  22. Yasunori M, Tomomi H, Kenji S, Harumi O (1992) Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J Pharm Pharmacol 44(8):634–639. https://doi.org/10.1111/j.2042-7158.1992.tb05484.x

    Article  Google Scholar 

  23. Morimoto S, Nagata S, Yamaguchi S, Fujino Y (1990) Depth profiling of deuterium implanted in thin films by the elastic recoil detection technique of transmission geometry. Nucl Instrum Methods Phys Res Sect B 48(1):478–481. https://doi.org/10.1016/0168-583X(90)90165-Q

    Article  Google Scholar 

  24. Mohamed LA, Kamal N, Elfakhri KH, Willett D, Wokovich A, Strasinger C, Cruz CN, Raney SG, Ashraf M, Zidan AS (2020) Drug recrystallization in drug-in-adhesive transdermal delivery system: a case study of deteriorating the mechanical and rheological characteristics of testosterone TDS. Int J Pharm 578:119132

    Article  CAS  Google Scholar 

  25. Parhi R, Padilam S (2018) In vitro permeation and stability studies on developed drug-in-adhesive transdermal patch of simvastatin. Bull Fac Pharm Cairo Univ 56(1):26–33

    Google Scholar 

  26. Pichayakorn W, Suksaeree J, Boonme P, Taweepreda W, Amnuaikit T, Ritthidej GC (2013) Deproteinised natural rubber used as a controlling layer membrane in reservoir-type nicotine transdermal patches. Chem Eng Res Des 91(3):520–529. https://doi.org/10.1016/j.cherd.2012.09.011

    Article  CAS  Google Scholar 

  27. Murphy M, Carmichael AJ (2000) Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Am J Clin Dermatol 1(6):361–368. https://doi.org/10.2165/00128071-200001060-00004

    Article  CAS  PubMed  Google Scholar 

  28. Kulkarni S (2019) Formulation and evaluation of transdermal patch for atomoxetine hydrochloride. J Drug Deliv Therap 9(2A):32–35

    CAS  Google Scholar 

  29. Nair AB, Gupta S, Al-Dhubiab BE, Jacob S, Shinu P, Shah J, Aly Morsy M, SreeHarsha N, Attimarad M, Venugopala KN (2019) Effective therapeutic delivery and bioavailability enhancement of pioglitazone using drug in adhesive transdermal patch. Pharmaceutics 11(7):359

    Article  CAS  Google Scholar 

  30. Prodduturi S, Smith GJ, Wokovich AM, Doub WH, Westenberger BJ, Buhse L (2009) Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation. Pharm Res 26(6):1344–1352

    Article  CAS  Google Scholar 

  31. Benecke AG, Kinne DJ, Wnuk AJ (1991) Storage-stable transdermal patch. Google Patents

Download references

Acknowledgements

The authors desire to show their gratitude to Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi for laboratory facilities to conduct this study. This study was supported by the research grant funded by National Research Program for Universities (NRPU) by Higher Education Commission Pakistan (6583/Sindh).

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, 75270, Pakistan

    Muhammad Suleman Imtiaz, Muhammad Harris Shoaib, Rabia Ismail Yousuf, Fatima Ramzan Ali, Muhammad Talha Saleem, Momina Zarish Khan & Muhammad Sikandar

Authors
  1. Muhammad Suleman Imtiaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Muhammad Harris Shoaib
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rabia Ismail Yousuf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fatima Ramzan Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Muhammad Talha Saleem
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Momina Zarish Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Muhammad Sikandar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muhammad Harris Shoaib.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Imtiaz, M.S., Shoaib, M.H., Yousuf, R.I. et al. Formulation development and evaluation of drug-in-adhesive-type transdermal patch of metoclopramide HCl. Polym. Bull. 79, 1187–1200 (2022). https://doi.org/10.1007/s00289-021-03559-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00289-021-03559-3

Keywords

Search

Navigation